Lipid Profile Changes in Type 2 Diabetes Mellitus after Treatment with Metformin
Abstract
Background
Insulin resistance and type 2 Diabetes Mellitus (T2DM) are associated with a clustering of interrelated plasma lipid and lipoprotein abnormalities. Treating uncontrolled glucose levels can indirectly improve lipids. Evidence suggest that, Metformin can decrease the TG's by 10% and LDL-C by 10 to 15% and increase the HDL-C by up to 7% beyond its glucose lowering properties. Considering very limited studies focusing this issue, the study was planned to assess the changes in lipid profile following metformin therapy.
Methods
This hospital based prospective and longitudinal study was conducted in outpatient Department of Medicine in Rangpur Medical college Hospital (RpMCH), for six months period from 4th November 2018 to 3rd May of 2019 following approval of this protocol. People with T2DM having dyslipidemia attending in OPD of Medicine department were approached for inclusion of the study. All patients were followed up by two times: at day 0, and day 60. Relevant investigation were performed to achieve the objective of the study.
Results
Among 300 patients, 52% were males and 48% were females. Mean age was 45.65±11.51 years, ranging from 25 to 71 years. Majority patients (39%) were aged >50 years. Among all, 60% patients came from urban area and 40% came from rural area. Base line (day 0) TC, LDL, HDL and TG level were 192.55±52.21 mg/dl, 110.99±28. 11mg/dl, 43.16±9.64 mg/dl and 192.01±100.46 mg/dl. At day 60, the level of TC, LDL, HDL and TG level has changed into 182.50±51.84 mg/dl, 100.93±28. 09mg/dl, 45.17±9.66 mg/dl and 171.65±72.08 mg/dl, respectively. Further analysis showed that this changes were statistically significant (p<0.05 in all cases).
Conclusion
Metformin has a beneficial role in lipid profile in newly detected type 2 DM patients.
Keywords:
Lipid profile
Type 2 Diabetes Mellitus
Metformin